Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

The Clinical Factors Related to the Efficacy of Ozoralizumab in Patients with Rheumatoid Arthritis

Background/Objectives: Ozoralizumab, a tumor necrosis factor (TNF) blocker, was launched in Japan in 2022. However, there is no evidence to determine whether this biological agent is the best choice for patients with rheumatoid arthritis (RA). To investigate the clinical factors related to the efficacy of ozoralizumab,...

K. Kanbe, A. Kubota · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.